Resultados de la búsqueda 981-990 of 14984 for effets à long terme du Doliprane

  1. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...

  2. Mayo Clinic

    Share · Tweet. July 29, 2021 . VID-20505630. Inicio; Remote Patient Monitoring. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo?

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate nab-paclitaxel as maintenance therapy after cisplatin-based chemotherapy and surgery in treating patients with ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  7. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients' tumors will be sequenced during a pre-registration component or will have had successful sequencing pre-study. A personalized neoantigen peptide ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...